相关实验视频
Updated: Jun 15, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
低血糖发作加剧了2型糖尿病中骨肌肉的胰岛素耐药性
Hendra Zufry1,2,3, Rosdiana Rosdiana4, Krishna Wardhana Sucipto1,2,3
1Division of Endocrinology, Department of Internal Medicine, Metabolism, and Diabetes, Thyroid Center, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
低血糖或低血糖显著恶化骨肌肉中的胰岛素抵抗. 这项研究发现,氧酶增殖器激活受体合激活剂1-alpha (PGC-1α) 和Akt水平随着糖尿病大鼠降低血糖的严重程度的增加而下降.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 糖尿病学 糖尿病学
背景情况:
- 骨肌中的胰岛素抵抗是2型糖尿病的一个关键因素.
- 低血糖症对骨肌肉胰岛素抵抗的确切影响尚不完全理解.
研究的目的:
- 为了研究低血糖对骨肌肉胰岛素抵抗的影响.
- 评估低血糖症与糖尿病大鼠骨肌肉和血中氧酶增殖器激活受体马协活性剂1-alpha (PGC-1α) 和Akt水平之间的相关性.
主要方法:
- 一项控制的实验研究,使用链毒素诱导的糖尿病大鼠 (Rattus norvegicus).
- 鼠被分为对照组,没有低血糖的糖尿病组,轻度低血糖组和严重的低血糖组.
- 骨肌肉 (四肢骨) 和血样本使用酶相关免疫吸收试验分析了PGC-1α和Akt水平.
主要成果:
- 低血糖症的严重程度与骨肌肉和血中的PGC-1α和Akt水平降低相关.
- 观察到较低的PGC-1α和Akt水平与更严重的低血糖症.
- 在两种组织中,PGC-1α和Akt水平之间发现了正相关性,表明相互依赖.
结论:
- 低血糖,即使是轻微的发作,也会显著损害骨肌肉中的胰岛素抵抗.
- 骨肌肉和血中的PGC-1α和Akt水平是低血糖在糖尿病疾病的影响的敏感指标.
更多相关视频
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
相关概念视频
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones